Skip to content

Efficacy of Acupuncture for Psychological Symptoms Associated with Opioid Addiction: A Systematic Review and Meta-Analysis

Zhang et al. · Evidence-Based Complementary and Alternative Medicine · 2014

📊Systematic Review and Meta-analysis👥n=1,599 participants⚠️Limited methodological quality
🎯

OBJECTIVE

Systematically evaluate the efficacy of acupuncture in the treatment of psychological symptoms (anxiety, depression, and craving) associated with opioid addiction

👥

WHO

1,599 opioid/heroin-dependent participants, including studies from China and Western countries

⏱️

DURATION

Interventions ranged from 4 days to 2 months, without long-term follow-up

📍

POINTS

Neiguan (PC-6), Zusanli (ST-36), Sanyinjiao (SP-6), Shenmen (HT-7), auricular points (liver, kidney, lung)

🔬 Study Design

1599participants
randomization

Acupuncture

n=799

Body, auricular, or electroacupuncture

Control

n=800

Placebo, standard medication, or no treatment

⏱️ Duration: 4 days to 2 months

📊 Results in numbers

SMD = 1.21

Improvement in anxiety vs placebo

SMD = 2.22

Improvement in depression vs placebo

SMD = 0.68

Reduction in craving vs no treatment

11/12

Chinese studies with positive results

0/4

Western studies with positive results

Percentage highlights

11/12
Chinese studies with positive results
0/4
Western studies with positive results

📊 Outcome Comparison

Improvement in anxiety (SMD)

Acupuncture
1.21
Placebo
0

Improvement in depression (SMD)

Acupuncture
2.22
Placebo
0
💬 What does this mean for you?

This research analyzed 16 studies to see whether acupuncture can help people addicted to opioid drugs with problems such as anxiety, depression, and drug craving. The results suggest that acupuncture may help with anxiety and depression, but the quality of the studies was low, so more research is needed to be certain.

📝

Article summary

Plain-language narrative summary

This study represents the first systematic review and meta-analysis focused specifically on the efficacy of acupuncture for treating psychological symptoms associated with opioid addiction. The researchers analyzed 16 randomized controlled studies involving 1,599 opioid- or heroin-dependent participants, published through January 2014. The research was motivated by the high prevalence of psychological symptoms such as anxiety, depression, and drug craving in people addicted to opioids, factors that contribute significantly to relapses.

The methodology included searches in MEDLINE and China Knowledge Resource Integrated Database, with rigorous inclusion and exclusion criteria. The studies were evaluated using the Jadad scale for methodological quality. Interestingly, there was a marked difference between studies published in English versus Chinese: all four studies from Western countries did not report clinical benefits of acupuncture, while 11 of 12 Chinese studies reported positive results.

The types of acupuncture varied across studies: Western studies primarily used auricular acupuncture (ear points such as liver, kidney, lung, Shenmen), while Chinese studies preferred body acupuncture with points such as Neiguan (PC-6), Zusanli (ST-36), Sanyinjiao (SP-6), and Shenmen (HT-7). Some studies also used electroacupuncture and point stimulators.

The meta-analysis revealed mixed results. For drug craving, there were no significant differences between acupuncture and placebo, standard medication, or sham acupuncture, except when compared with no treatment. For anxiety, acupuncture showed significant improvements compared with placebo (SMD = 1.21), medication (SMD = 0.32), and no treatment (SMD = 0.82). For depression, based on only two studies, acupuncture was superior to placebo (SMD = 2.22) and no treatment (SMD = 1.99).

Methodological quality was a major concern. The mean Jadad score was 3.50 for English studies versus 1.92 for Chinese studies. Only six studies received a score of ≥3, considered high quality. Limitations included inadequate description of randomization, lack of appropriate blinding, absence of long-term follow-up, and very short treatment protocols (most less than one month).

Proposed mechanisms include modulation of neurotransmitters such as dopamine and GABA, as well as effects on brain structures such as the nucleus accumbens and amygdala, important in addiction and associative memory processes. Animal studies suggest that acupuncture may suppress drug-induced dopamine release and reduce postsynaptic neuronal activity in areas related to reinforcement.

Clinical implications are limited by the heterogeneity of studies and variable methodological quality. Although there are promising signals for the treatment of anxiety and depression, the evidence is insufficient to recommend acupuncture as an established treatment for psychological symptoms in opioid-dependent individuals. The discrepancy between Chinese and Western studies raises questions about publication bias, cultural differences in acupuncture practice, and methodological standards.

Strengths

  • 1First systematic review focused on specific psychological symptoms
  • 2Included relevant Chinese literature frequently overlooked
  • 3Comprehensive meta-analysis with different comparisons
  • 4Systematic evaluation of methodological quality
⚠️

Limitations

  • 1Generally low methodological quality of included studies
  • 2Absence of long-term follow-up in all studies
  • 3Significant heterogeneity among acupuncture protocols
  • 4Possible publication bias especially in Chinese studies
Dr. Marcus Yu Bin Pai

Expert Commentary

Dr. Marcus Yu Bin Pai

MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture

Clinical Relevance

Opioid dependence imposes on the clinician a challenge that goes well beyond physical abstinence: persistent anxiety, depression, and craving are the main drivers of relapse and rarely respond satisfactorily to pharmacotherapy alone. This systematic review, by consolidating 1,599 participants across 16 trials, places acupuncture as a plausible adjuvant candidate in this specific context. The effects on anxiety — SMD of 1.21 versus placebo — and depression — SMD of 2.22 — are numerically expressive and suggest that the intervention may occupy real space within multidisciplinary dependence treatment programs. In the practice of pain and rehabilitation services, we are increasingly encountering patients transitioning from prescribed opioids to abstinence, a population for whom any resource that attenuates psychic suffering during withdrawal has concrete clinical value and may reduce the probability of restarting use.

Notable Findings

The radical divergence between the results of Chinese studies — 11 of 12 positive — and Western studies — none of the 4 positive — is the data that most deserves attention from anyone routinely dealing with acupuncture literature. It does not reflect only publication bias; it also points to substantial protocol differences: Western studies favored auricular acupuncture with few points, while Chinese studies combined body points such as Neiguan (PC-6), Zusanli (ST-36), and Sanyinjiao (SP-6), neurophysiologically more robust protocols for dopaminergic and GABAergic modulation. The reduction in craving was significant only versus no treatment, which is clinically honest: the anti-craving effect appears to depend more on the care context than on the needle itself. The proposed mechanisms — modulation of the nucleus accumbens and suppression of opioid-induced dopamine release — are coherent with what addiction neuroscience literature already documents.

From My Experience

In my practice in the pain service, the most frequent situation is not the heroin-dependent patient of the Asian studies, but the patient with chronic pain in programmed withdrawal from prescribed opioids, who arrives with background anxiety and depressed mood that amplify pain perception and stall the process. I have observed that body acupuncture with emphasis on PC-6, HT-7, and SP-6, combined with needling of active trigger points, produces a response on the anxious component as early as the first three to four sessions, which coincides with the critical window of relapse risk. I usually conduct eight to twelve sessions during the withdrawal phase, combining it with a supervised aerobic exercise program and, when indicated, psychiatric support with bupropion or mirtazapine. The profile that responds best, in my experience, is the patient with prominent somatic anxiety and fragmented sleep — exactly where the neuromodulation of acupuncture seems to have the most clinical traction.

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture.

Full original article

Read the full scientific study

Evidence-Based Complementary and Alternative Medicine · 2014

DOI: 10.1155/2014/313549

Access original article

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.